Screening and brief interventions for alcohol misuse delivered in the community pharmacy setting

Screening and brief interventions for alcohol misuse delivered in the community pharmacy setting: a pilot study using a pragmatic cluster randomised controlled trial design

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN40380499

Enrollment

100

Registered

2010-03-16

Start date

2010-02-05

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol misuse Mental and Behavioural Disorders Mental and behavioural disorders due to use of alcohol

Interventions

Each pharmacy will be required to screen 100 clients within a two-month period. Based on the proof-of-concept studies, 40% are expected to be identified as harmful or hazardous drinkers. All adult

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Community pharmacists and staff from 20 community pharmacies (i.e. 10 pharmacies in each group) 2. Adult clients presenting in participating community pharmacies 3. Clients aged 18 or over, either sex

Exclusion criteria

Exclusion criteria: 1. Clients who have already been screened 2. Received an alcohol brief intervention elsewhere 3. Clients identified as dependent drinkers

Design outcomes

Primary

Measure	Time frame
1. Average screening rate per pharmacy per week 2. Average recruitment rate per pharmacy per week 3. Number or proportion of clients who score greater than 3 using FAST 4. Self-reported measures of alcohol consumption (which may include number of episodes of 'binge' drinking, alcohol free days) 5. Follow-up rate at three and six months 6. Number of referrals to other agencies 7. Identification of barriers and facilitators to delivering screening and brief interventions in the community pharmacy setting (pharmacy staff and client perspective) 8. Exploration of the public's opinion of screening and brief interventions in the community pharmacy setting Data to derive outcome measures (e.g. FAST score, other measures of alcohol consumption) will be collected at baseline, three and six months. Baseline data will be collected by pharmacy staff during the screening process and pharmacist consultation. Data at three and six months will be collected from clients using mailed questionnaires. The pharmacists and staff will be required to document additional information including the duration of screening and brief intervention consultations.	—

Measure

Time frame

1. Average screening rate per pharmacy per week 2. Average recruitment rate per pharmacy per week 3. Number or proportion of clients who score greater than 3 using FAST 4. Self-reported measures of alcohol consumption (which may include number of episodes of 'binge' drinking, alcohol free days) 5. Follow-up rate at three and six months 6. Number of referrals to other agencies 7. Identification of barriers and facilitators to delivering screening and brief interventions in the community pharmacy setting (pharmacy staff and client perspective) 8. Exploration of the public's opinion of screening and brief interventions in the community pharmacy setting Data to derive outcome measures (e.g. FAST score, other measures of alcohol consumption) will be collected at baseline, three and six months. Baseline data will be collected by pharmacy staff during the screening process and pharmacist consultation. Data at three and six months will be collected from clients using mailed questionnaires. The pharmacists and staff will be required to document additional information including the duration of screening and brief intervention consultations.

—

Secondary

Measure	Time frame
No secondary outcome measures	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026